{"id":"W4281761035","doi":"10.1200/jco.2022.40.16_suppl.e19522","title":"A phase 2 expanded access study of zanubrutinib (ZANU) in patients (pts) with Waldenström Macroglobulinemia (WM).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse effect; Chemoimmunotherapy; Internal medicine; Expanded access; Bruton's tyrosine kinase; Waldenstrom macroglobulinemia; Gastroenterology; Tyrosine kinase; Rituximab; Lymphoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001670467,0.001174993,0.001530245,0.0003145513,0.000335307,0.0008643944,0.0005605061,0.0008728722,0.006006391],"category_scores_gemma":[0.0009167425,0.000487762,0.0008848041,0.0003600173,0.0004358879,0.0008721506,0.0004682259,0.00237156,0.001184451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006668945,"about_ca_system_score_gemma":0.001154865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008558746,"about_ca_topic_score_gemma":0.002860106,"domain_scores_codex":[0.9996589,0.0001770909,0.00001577192,0.00005251369,0.00003697817,0.00005875424],"domain_scores_gemma":[0.9995376,0.00005688169,0.00008021809,0.00002627398,0.00003329741,0.0002659043],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7970257,0.06048854,0.01854995,0.001088352,0.001963272,0.0006818534,0.0003770104,0.001658927,0.02637181,0.0002977456,0.008192625,0.08330419],"study_design_scores_gemma":[0.7711585,0.1939349,0.02721108,0.00004088574,0.0006855358,0.0004529307,0.000072692,0.0007346709,0.0009666779,0.0001905358,0.004531549,0.00002002329],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877741,0.002198913,0.0005386886,0.0004868537,0.0001332919,0.004136564,0.001955708,0.00007292812,0.002703043],"genre_scores_gemma":[0.9847224,0.001812173,0.001559702,0.001160244,0.0001793727,0.004092878,0.003124421,0.00003154381,0.003317227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006006391,"threshold_uncertainty_score":0.02009338,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1512632678681934,"score_gpt":0.5337357547382141,"score_spread":0.3824724868700207,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}